11/14
12:07 pm
ntra
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Morgan Stanley from $132.00 to $176.00. They now have an "overweight" rating on the stock.
Low
Report
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Morgan Stanley from $132.00 to $176.00. They now have an "overweight" rating on the stock.
11/14
03:12 am
ntra
Natera, Inc. (NASDAQ: NTRA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Natera, Inc. (NASDAQ: NTRA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/13
01:45 pm
ntra
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at TD Cowen from $155.00 to $175.00. They now have a "buy" rating on the stock.
Low
Report
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at TD Cowen from $155.00 to $175.00. They now have a "buy" rating on the stock.
11/13
11:38 am
ntra
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Craig Hallum from $121.00 to $157.00. They now have a "buy" rating on the stock.
Medium
Report
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Craig Hallum from $121.00 to $157.00. They now have a "buy" rating on the stock.
11/13
11:28 am
ntra
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at JPMorgan Chase & Co. from $135.00 to $160.00. They now have an "overweight" rating on the stock.
Medium
Report
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at JPMorgan Chase & Co. from $135.00 to $160.00. They now have an "overweight" rating on the stock.
11/13
09:34 am
ntra
Global Preterm Birth Diagnostic Test Kit Market Set for Strong Growth, Projected to Reach USD 316.5 Million by 2034: Key Growth Drivers and Trends | Future Market Insights, Inc. [Yahoo! Finance]
Low
Report
Global Preterm Birth Diagnostic Test Kit Market Set for Strong Growth, Projected to Reach USD 316.5 Million by 2034: Key Growth Drivers and Trends | Future Market Insights, Inc. [Yahoo! Finance]
11/13
08:28 am
ntra
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $150.00 to $165.00. They now have a "buy" rating on the stock.
Medium
Report
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $150.00 to $165.00. They now have a "buy" rating on the stock.
11/13
08:05 am
ntra
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Robert W. Baird from $120.00 to $160.00. They now have an "outperform" rating on the stock.
Medium
Report
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Robert W. Baird from $120.00 to $160.00. They now have an "outperform" rating on the stock.
11/13
02:26 am
ntra
Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ... [Yahoo! Finance]
Medium
Report
Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ... [Yahoo! Finance]
11/13
12:12 am
ntra
Decoding Natera Inc (NTRA): A Strategic SWOT Insight [Yahoo! Finance]
Medium
Report
Decoding Natera Inc (NTRA): A Strategic SWOT Insight [Yahoo! Finance]
11/12
08:04 pm
ntra
Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
11/12
08:04 pm
ntra
Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Medium
Report
Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
11/12
04:41 pm
ntra
Natera Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Natera Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/12
04:05 pm
ntra
Natera Reports Third Quarter 2024 Financial Results
High
Report
Natera Reports Third Quarter 2024 Financial Results
11/12
07:00 am
ntra
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
Low
Report
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
11/11
07:12 am
ntra
Natera Inc (NTRA) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
Low
Report
Natera Inc (NTRA) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
11/8
09:00 am
ntra
Natera to Participate in Upcoming Investor Conferences
Low
Report
Natera to Participate in Upcoming Investor Conferences
11/6
02:05 am
ntra
Natera, Inc. (NASDAQ: NTRA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Natera, Inc. (NASDAQ: NTRA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
11/1
09:00 am
ntra
Natera to Report its Third Quarter 2024 Results on November 12, 2024
Low
Report
Natera to Report its Third Quarter 2024 Results on November 12, 2024
10/30
03:35 pm
ntra
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Sanford C. Bernstein from $125.00 to $135.00. They now have an "outperform" rating on the stock.
Low
Report
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Sanford C. Bernstein from $125.00 to $135.00. They now have an "outperform" rating on the stock.
10/29
09:17 am
ntra
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $145.00 to $150.00. They now have a "buy" rating on the stock.
Medium
Report
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $145.00 to $150.00. They now have a "buy" rating on the stock.
10/25
02:07 am
ntra
Natera, Inc. (NASDAQ: NTRA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Natera, Inc. (NASDAQ: NTRA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
10/22
09:00 am
ntra
Natera to Present New Renasight Data at ASN Kidney Week 2024
Low
Report
Natera to Present New Renasight Data at ASN Kidney Week 2024
10/17
11:10 pm
ntra
Natera, Inc. (NASDAQ: NTRA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Natera, Inc. (NASDAQ: NTRA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
10/17
11:36 am
ntra
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Leerink Partners from $140.00 to $150.00. They now have an "outperform" rating on the stock.
Low
Report
Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Leerink Partners from $140.00 to $150.00. They now have an "outperform" rating on the stock.